The AMEX Biotechnology Index gained 0.56 points to 140.82 onWednesday, despite profit taking on Amgen Inc., which fell$2.38 to $55 after gaining $2.88 on Tuesday. Based on afavorable earnings report, Genzyme Corp. added $1.38 to its$2.13 gain Tuesday to close at $40.50.

(c) 1997 American Health Consultants. All rights reserved.